lobbying_activities: 1295815

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1295815	8af6d82a-414a-462e-aad9-90e8d8781687	Q3	HOLLAND & KNIGHT LLP	18466	SAFECOR HEALTH, LLC	2012	third_quarter	PHA	Drug supply chain provisions in federal legislation; specifically S.3187, The Food & Drug Administration Safety & Innovation Act and H.R. 5651, The Food & Drug Administration Reform Act of 2012. Advocated for provisions recognizing the role of drug repackagers and against provisions to make certain hydrocodone products schedule 2 controlled substances.	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2012-10-08T14:03:35.477000-04:00